Q1 2018

iRhythm Technologies, maker of the Zio XT and Zio AT adhesive heart monitors, announced first quarter financials boasting higher revenue and an improved gross margin during an earnings call for investors earlier this week.

Amidst big gains in total revenue, memberships, and user engagement, Q1 2018 earnings reported by Teladoc show that the telemedicine company is still a long way from turning a profit.

Pharma companies have been eying digital health with interest, and the first quarter of 2018 was no exception.

Digital health-focused news from payers during the first quarter of 2018 generally focused on employee wellness and app-focused member engagement strategies, with a handful of similar partnerships or deals announced around the edges.

Rock Health and StartUp Health, two groups that track investment in digital health, have come out with their respective quarterly reports on funding in the space, and both agree on a couple of interesting insights: that Q1 2018 is the largest Q1 yet, that larger late-stage deals contributed disproportionately to that total, and that investment is increasingly coming from non-traditional investors, especially providers.

In the first three months of 2018, MobiHealthNews tracked 30 digital funding rounds comprising approximately $1.